{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:12:13Z","timestamp":1795065133721,"version":"4.10.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is a refractory osteonecrosis caused by antiresorptive agents such as bisphosphonate and denosumab (DMB). In MRONJ surgery, computed tomography (CT) is generally used to determine the extent of bone resection. However, in some recent MRONJ cases, no abnormal findings were detected on CT. Therefore, we aimed to clarify the characteristics of MRONJ without osteolysis. This retrospective and observational study included 18 patients diagnosed with MRONJ between October 2020 and October 2022 at Department of Dentistry and Oral Surgery, Kansai Medical University Medical Center. In four of 18 patients with MRONJ, no abnormal findings such as osteolysis, separation of sequestrum, and periosteal reaction were observed on CT images at the first visit. All four patients with non-osteolytic MRONJ had malignant tumors and received high-dose DMB, and in the four patients there were no preceding dental infections such as apical lesions or periodontal disease and the trigger of MRONJ was unknown. Surgery was performed in three of the four patients. The extent of bone resection was determined using magnetic resonance imaging and intraoperative gross findings. In the future, it is necessary to establish a method for diagnosing non osteolytic MRONJ and determining the extent of bone resection.<\/jats:p>","DOI":"10.1038\/s41598-023-39755-6","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T06:01:36Z","timestamp":1691560896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study"],"prefix":"10.1038","volume":"13","author":[{"given":"Yuki","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"39755_CR1","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.joms.2021.12.007","volume":"80","author":"M Ishimaru","year":"2022","unstructured":"Ishimaru, M. et al. Prevalence, incidence rate, and risk factors of medication-related osteonecrosis of the jaw in patients with osteoporosis and cancer: A nationwide population-based study in Japan. J. Oral Maxillofac. Surg. 80, 714\u2013727 (2022).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"39755_CR2","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero, S. L. et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J. Oral Maxillofac. Surg. 72, 1938\u20131956 (2014).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"39755_CR3","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/jbmr.3191","volume":"32","author":"S Hayashida","year":"2017","unstructured":"Hayashida, S. et al. Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: A multicenter retrospective study with propensity score matching analysis. J. Bone Miner. Res. 32, 2022\u20132029 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"39755_CR4","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.joms.2012.05.019","volume":"70","author":"F Graziani","year":"2012","unstructured":"Graziani, F. et al. Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: A retrospective survey of 347 cases. J. Oral Maxillofac. Surg. 70, 2501\u20132507 (2012).","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"Supplement","key":"39755_CR5","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","volume":"73","author":"SL Ruggiero","year":"2015","unstructured":"Ruggiero, S. L. & Kohn, N. Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw. J. Oral Maxillofac. Surg. 73(Supplement), S94\u2013S100 (2015).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"39755_CR6","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.joms.2016.12.014","volume":"75","author":"HY Kim","year":"2017","unstructured":"Kim, H. Y. et al. Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis. J. Oral Maxillofac. Surg. 75, 1404\u20131413 (2017).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"39755_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","volume":"50","author":"K Rupel","year":"2014","unstructured":"Rupel, K. et al. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol. 50, 1049\u20131057 (2014).","journal-title":"Oral Oncol."},{"key":"39755_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","volume":"44","author":"R Fliefel","year":"2015","unstructured":"Fliefel, R., Tr\u00f6ltzsch, M., K\u00fchnisch, J., Ehrenfeld, M. & Otto, S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: A systematic review. Int. J. Oral Maxillofac. Surg. 44, 568\u2013585 (2015).","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"39755_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan, A. A. et al. Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus. J. Bone Miner. Res. 30, 3\u201323 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"39755_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero, S. L. et al. American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on medication-related osteonecrosis of the jaws-2022 update. J. Oral Maxillofac. Surg. 80, 920\u2013943 (2022).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"39755_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00774-019-00994-1","volume":"37","author":"Y Kojima","year":"2019","unstructured":"Kojima, Y. et al. Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. J. Bone Miner. Metab. 37, 913\u2013919 (2019).","journal-title":"J. Bone Miner. Metab."},{"key":"39755_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00774-020-01154-6","volume":"39","author":"S Soutome","year":"2021","unstructured":"Soutome, S. et al. Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery. J. Bone Miner. Metab. 39, 302\u2013310 (2021).","journal-title":"J. Bone Miner. Metab."},{"key":"39755_CR13","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1007\/s00520-021-06214-9","volume":"29","author":"S Soutome","year":"2021","unstructured":"Soutome, S. et al. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): Clinical significance and changes during conservative therapy. Support. Care Cancer 29, 6361\u20136368 (2021).","journal-title":"Support. Care Cancer"},{"key":"39755_CR14","first-page":"33","volume":"61","author":"DD Damm","year":"2013","unstructured":"Damm, D. D. & Jones, D. M. Bisphosphonate-related osteonecrosis of the jaws: A potential alternative to drug holidays. Gen. Dent. 61, 33\u201338 (2013).","journal-title":"Gen. Dent."},{"key":"39755_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12967-019-1819-1","volume":"17","author":"F Wehrhan","year":"2019","unstructured":"Wehrhan, F. et al. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: A comparison with osteoradionecrosis and osteomyelitis. J. Transl. Med. 17, 69 (2019).","journal-title":"J. Transl. Med."},{"key":"39755_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","volume":"7","author":"PD Miller","year":"2009","unstructured":"Miller, P. D. Denosumab: Anti-RANKL antibody. Curr. Osteoporos. Rep. 7, 18\u201322 (2009).","journal-title":"Curr. Osteoporos. Rep."},{"key":"39755_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3892\/mco.2015.696","volume":"4","author":"Y Matsushita","year":"2016","unstructured":"Matsushita, Y. et al. Denosumab-associated osteonecrosis of the jaw affects osteoclast formation and differentiation: Pathological features of two cases. Mol. Clin. Oncol. 4, 191\u2013194 (2016).","journal-title":"Mol. Clin. Oncol."},{"key":"39755_CR18","first-page":"e326","volume":"25","author":"A Limones","year":"2020","unstructured":"Limones, A. et al. Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab vs. zoledronic acid: A systematic review and meta-analysis. Med. Oral Patol. Oral Cir. Bucal 25, e326\u2013e336 (2020).","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"39755_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12253-012-9538-4","volume":"2016","author":"L Kopper","year":"2012","unstructured":"Kopper, L. Denosumab\u2014A powerful RANKL inhibitor to stop lytic metastases and other bone loss actions by osteoclasts. Pathol. Oncol. Res. 2016, 743\u2013747 (2012).","journal-title":"Pathol. Oncol. Res."},{"key":"39755_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.oooo.2019.09.010","volume":"129","author":"SE Pichardo","year":"2020","unstructured":"Pichardo, S. E., Broek, F. W., Fiocco, M., Appelman-Dijkstra, N. M. & van Merkesteyn, J. P. A comparison of the cone beam computed tomography findings in medication-related osteonecrosis of the jaws related to denosumab versus bisphosphonates: An observational pilot study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 129, 411\u2013417 (2020).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"39755_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1801676","volume":"8","author":"G Favia","year":"2016","unstructured":"Favia, G., Tempesta, A., Limongelli, L., Crincoli, V. & Maiorano, E. Medication-related osteonecrosis of the jaws: Considerations on a new antiresorptive therapy (Denosumab) and treatment outcome after a 13-year experience. Int. J. Dent. 8, 1\u20139 (2016).","journal-title":"Int. J. Dent."},{"key":"39755_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.oooo.2019.11.006","volume":"129","author":"JW Shin","year":"2020","unstructured":"Shin, J. W. et al. Computed tomography imaging features of osteomyelitis of the jaw: comparison between antiresorptive medication-related conditions and medication-unrelated conditions. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 129, 629\u2013634 (2020).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"39755_CR23","doi-asserted-by":"publisher","first-page":"20200417","DOI":"10.1259\/dmfr.20200417","volume":"50","author":"P Wongratwanich","year":"2021","unstructured":"Wongratwanich, P. et al. Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review. Dentomaxillofac. Radiol. 50, 20200417 (2021).","journal-title":"Dentomaxillofac. Radiol."},{"key":"39755_CR24","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/j.oooo.2016.11.007","volume":"123","author":"G Subramanian","year":"2017","unstructured":"Subramanian, G. et al. Identifying MRONJ-affected bone with digital fusion of functional imaging (FI) and cone-beam computed tomography (CBCT): Case reports and hypothesis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 123, e106\u2013e116 (2017).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"39755_CR25","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1590\/1807-3107bor-2018.vol32.0023","volume":"32","author":"CC De Antoni","year":"2018","unstructured":"De Antoni, C. C. et al. Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study. Braz. Oral. Res. 32, e23 (2018).","journal-title":"Braz. Oral. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39755-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39755-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39755-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T19:05:19Z","timestamp":1700334319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39755-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39755"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39755-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2667138\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"7 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12890"}}